Piperacillin-tazobactam and netilmicin as a safe and efficacious empirical treatment of febrile neutropenic children

Supportive Care in Cancer

Volumn 12, Issue 10, 2004, Pages 720-724

  Le Guyader, N ^a   Auvrignon, A ^a   Vu Thien, H ^a   Portier, E ^a   Tabone, M D ^a   Leverger, G ^a  

^a ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

Children; Fever; Neutropenia; Piperacillin; Tazobactam

Indexed keywords

AMIKACIN; AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; BETA LACTAMASE INHIBITOR; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; GLYCOPEPTIDE; IMIPENEM; NETILMICIN; PIPERACILLIN PLUS TAZOBACTAM; TEICOPLANIN; TICARCILLIN; VANCOMYCIN;

ADOLESCENT; ADULT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATION; BLOOD CULTURE; CHILD; CLINICAL PROTOCOL; COAGULASE NEGATIVE STAPHYLOCOCCUS; DRUG CHOICE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ESCHERICHIA COLI; EVALUATION; FEBRILE NEUTROPENIA; HEMATOLOGIC MALIGNANCY; HUMAN; INFANT; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; PSEUDOMONAS AERUGINOSA; PYREXIA IDIOPATHICA; RASH; RECURRENT DISEASE; SOLID TUMOR; STREPTOCOCCUS MITIS; TREATMENT FAILURE;

ADOLESCENT; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; FEMALE; FEVER; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; NETILMICIN; NEUTROPENIA; PENICILLANIC ACID; PIPERACILLIN; RECURRENCE; TREATMENT OUTCOME;

EID: 5444262330     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-004-0641-2     Document Type: Article

References (23)

1. Arguedas A, Sifuentes-Osornio J, Loaiza C, Herrera M, Corrales JC, Mohs E (1996) An open, multicenter clinical trial of piperacillin-tazobactam in the treatment of pediatric patients with intra-abdominal infection. J Chemother 8:130-136
2. Bauduer F, Cousin T, Boulat O, Rigal-Huguet F, Molina L, Fegueux N, Jourdan E, Boiron JM, Reiffers J (2001) BGMT Collaborative Group. A randomized prospective multicentric trial of cefpirome versus piperacillin-tazobactam in febrile neutropenia. Leuk Lymphoma 42:379-386
3. Cometta A, Zinner S, de Bock R, Calandra T, Gaya H, Klastersky J, Langenaeken J, Paesmans M, Viscoli C, Glauser MP (1995) Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empirical therapy for fever in granulocytopenic patients with cancer. Antimicrob Agents Chemother 39:445-452
4. Cordonnier C, Herbrecht R, Pico JL, Gardembas M, Delmer A, Delain M, Moreau P, Ladeb S, Nalet V, Rollin C, Gres JJ (1997) Cefepime-amikacin vs ceftazidime-amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. Clin Infect Dis 24:41-51
5. De Pauw BE, Deresinski SC, Feld R, Lane-Allman EF, Donnelly JP (1999) Ceftazidime compared with piperacillin-tobramycin for the empiric treatment of febrile neutropenic patients with cancer. Ann Intern 120:834-844
6. Duez JM, Siebor E, Pechinot A, Cordin X, Chamard-Neuwirth C, Kazmierczak A (1995) In vitro antibacterial activity of piperacillin-tazobactam in combination with netilmicin or amikacin against Enterobacteriaceae resistant to amoxicillin. Pathol Biol 43:208-214
7. European Organization for Research and Treatment of Cancer (EORTC)-International Antimicrobial Therapy Cooperative Group, National Cancer Institute of Canada: Clinical Trials Group (1991). Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. J Infect Dis 163:951-958
8. European Organization for Research and Treatment of Cancer (EORTC)-International Antimicrobial Therapy Cooperative Group (1993) Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer granulocytopenia. Ann Intern Med 119:584-593
9. Feliu J, Artal A, Gonzalez Baron M, Berrocal A, Chacon I, Garcia de Paredes ML, Espinosa E, Ordonez A, Zamora P, Montero JM (1992) Comparison of two antibiotic regimens (Piperacillin plus amikacin versus ceftazidime plus amikacin) as empiric therapy for febrile neutropenic patients with cancer. Antimicrob Agents Chemother 36:2816-2820
10. Hann I, Viscoli C, Paesmans M, Gaya H, Glauser M (1997) A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies. Br J Haematol 99:580-588
11. Leyland MJ, Bayston KF, Cohen J, Warren R, Newland AC, Bint AJ, Cefai C, White DG, Murray SA, Bareford D et al (1992) A comparative study of imipenem versus piperacillin plus gentamicin in the initial management of febrile neutropenic patients with haematological malignancies. J Antimicrob Chemother 30:843-854
12. Fishman SJ, Pelosi L, Klavon SL, O'Rourke EJ (2000) Perforated appendicitis: prospective outcome analysis for 150 children. J Pediatr Surg 35:923-926
13. Hughes W, Armstrong D, Bodey G, Brown AE, Edwards JE, Feld R, Pizzo P, Rolston KV, Shenep JL (1997) Young LS. 1997 Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Clin Infect Dis 25:551-573
14. Nürnberger W, Bonig H, Burdach S, Gobel U (1998) Tolerability of piperacillin/tazobactam in children and adolescents after high dose radio/chemotherapy and autologous stem cell transplantation. Infection 26:65-67
15. Patterson JE, Hardin TC, Kelly CA, Garcia RC, Jorgensen JH (2000) Association of antibiotic utilization measures and control of multiple-drug resistance in Klebsiella pneumoniae. Infect Control Hosp Epidemiol 21:455-458
16. Payne DJ, Cramp R, Winstanley DJ, Knowles DJ (1994) Comparative activities of clavulanic acid, sulbactam, and tazobactam against clinically important beta-lactamases. Antimicrob Agents Chemother 38:767-772
17. Raad II, Whimbey EE, Rolston KV, Abi-Said D, Hachem RY, Pandya RG, Ghaddar HM, Karl CL, Bodey GP (1996) A comparaison of Aztreonam plus Vancomycin and Imipenem plus Vancomycin as initial therapy for febrile neutropenic cancer patients. Cancer 77:1386-94
18. Reed MD, Goldfarb J, Yamashita TS, Lemon E, Blumer JL (1994) Single-dose pharmacocinetics of piperacillin and tazobactam in infants and children. Antimicrob Agents Chemother 38:2817-2826
19. Rice LB, Eckstein EC, De Vente J, Shlaes DM (1996) Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland department of veterans affairs medical center. Clin Inf Dis 23:118-124
20. Rice LB (2001) Evolution and clinical importance of extended-spectrum β-lactamases. Chest 119:391S-396S
21. Thabaut A, Meyran M (1991) In vitro activity of piperacillin-tazobactam on 224 isolais of P. aeruginosa according to beta-lactamase production. Pathol Biol 39:361-366
22. Viscoli C (1998) The evolution of the empirical management of fever and neutropenia in cancer patients. J Antimicrob Chemother 41[Suppl D]: 65-80
23. Young M, Plosker GL (2001) Piperacillin/tazobactam: a pharmacoeconomic review of its use in moderate to severe bacterial infections. Pharmacoeconomics 19:1135-1175